Gerald M Lieberman - Net Worth and Insider Trading

Gerald M Lieberman Net Worth

The estimated net worth of Gerald M Lieberman is at least $557,255 dollars as of 2024-05-22. Gerald M Lieberman is the Director of Entera Bio Ltd and owns about 233,161 shares of Entera Bio Ltd (ENTX) stock worth over $557,255. Details can be seen in Gerald M Lieberman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gerald M Lieberman has not made any transactions after 2023-12-22 and currently still holds the listed stock(s).

Transaction Summary of Gerald M Lieberman

To

Gerald M Lieberman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gerald M Lieberman owns 3 companies in total, including Teva Pharmaceutical Industries Ltd (TEVA) , AllianceBernstein Holding LP (AB) , and Entera Bio Ltd (ENTX) .

Click here to see the complete history of Gerald M Lieberman’s form 4 insider trades.

Insider Ownership Summary of Gerald M Lieberman

Ticker Comapny Transaction Date Type of Owner
TEVA Teva Pharmaceutical Industries Ltd 2018-01-01 director
AB AllianceBernstein Holding LP 2003-08-20 EVP-Finance and Ops. of GP
ENTX Entera Bio Ltd 2023-12-22 director

Gerald M Lieberman Latest Holdings Summary

Gerald M Lieberman currently owns a total of 1 stock. Gerald M Lieberman owns 233,161 shares of Entera Bio Ltd (ENTX) as of December 22, 2023, with a value of $557,255.

Latest Holdings of Gerald M Lieberman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENTX Entera Bio Ltd 2023-12-22 233,161 2.39 557,255

Holding Weightings of Gerald M Lieberman


Gerald M Lieberman Form 4 Trading Tracker

According to the SEC Form 4 filings, Gerald M Lieberman has made a total of 5 transactions in Entera Bio Ltd (ENTX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Entera Bio Ltd is the acquisition of 23,952 shares on December 22, 2023, which cost Gerald M Lieberman around $17,006.

Insider Trading History of Gerald M Lieberman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gerald M Lieberman Trading Performance

GuruFocus tracks the stock performance after each of Gerald M Lieberman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gerald M Lieberman is 31.4%. GuruFocus also compares Gerald M Lieberman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gerald M Lieberman within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gerald M Lieberman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gerald M Lieberman

Average Return

Average return per transaction

Outperforming Transactions

1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.74
Relative Return to S&P 500(%) 6.32

Gerald M Lieberman Ownership Network

Ownership Network List of Gerald M Lieberman

No Data

Ownership Network Relation of Gerald M Lieberman


Gerald M Lieberman Owned Company Details

What does Teva Pharmaceutical Industries Ltd do?

Who are the key executives at Teva Pharmaceutical Industries Ltd?

Gerald M Lieberman is the director of Teva Pharmaceutical Industries Ltd. Other key executives at Teva Pharmaceutical Industries Ltd include Chief Accounting Officer Amir Weiss , See "Remarks" Vikki L Conway , and EVP & Chief Financial Officer Eliyahu Sharon Kalif .

Teva Pharmaceutical Industries Ltd (TEVA) Insider Trades Summary

Over the past 18 months, Gerald M Lieberman made no insider transaction in Teva Pharmaceutical Industries Ltd (TEVA). Other recent insider transactions involving Teva Pharmaceutical Industries Ltd (TEVA) include a net sale of 281,251 shares made by Richard Daniell , a net sale of 223,026 shares made by Eric Drape , and a net sale of 61,882 shares made by Amir Weiss .

In summary, during the past 3 months, insiders sold 406,547 shares of Teva Pharmaceutical Industries Ltd (TEVA) in total and bought 0 shares, with a net sale of 406,547 shares. During the past 18 months, 1,198,588 shares of Teva Pharmaceutical Industries Ltd (TEVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,198,588 shares.

Teva Pharmaceutical Industries Ltd (TEVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Teva Pharmaceutical Industries Ltd Insider Transactions

No Available Data

Gerald M Lieberman Mailing Address

Above is the net worth, insider trading, and ownership report for Gerald M Lieberman. You might contact Gerald M Lieberman via mailing address: C/o Alliance Capital, 1345 Avenue Of The Americas, New York Ny 10105.

Discussions on Gerald M Lieberman

No discussions yet.